News
A rare liver disorder in a newborn became the testbed for the first in vivo CRISPR therapy, led by Berkeley’s Innovative ...
The organizations launched the center with a $20 million CZI grant to build on the success of the first personalized CRISPR base-editing therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback